STAR-Too, NCT01349192: Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) |
|
|
| Terminated | 2 | 47 | US | Rifampin, Rifadin, Rimactane, Trimethoprim/Sulfamethoxazole, Bactrim, Septra, Minocycline, Cleeravue-M, Dynacin, Minocin, Myrac, Solodyn, Vectrin, Mupirocin, Bactroban, Centany, chlorhexidine gluconate oral rinse, 2% Chlorhexidine solution wipes, Environmental Decontamination, Sani-Cloth Plus | University of North Carolina, Chapel Hill, CF Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Washington University School of Medicine, University of Washington, University of Colorado, Denver, Baylor College of Medicine, University of Alabama at Birmingham, Cook Children's Medical Center, University of Michigan, University of Florida, University of Texas Southwestern Medical Center, Children's Hospital Medical Center, Cincinnati, St. Louis Children's Hospital | Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus | 01/15 | 05/15 | | |
